Eli Lilly (LLY) FY2018 results: revenue $21.5 billion, up 7.6% on the year
Eli Lilly & Co. (LLY) reported revenue of $21.5 billion for fiscal 2018, the year ended 31 December 2018, up 7.6% on the year before. Net income was $3.2 billion, and diluted earnings per share $3.13. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2019.
Revenue
$21.5 billion
+7.6% on the year
FY2011FY2018
Operating margin
n/a
FY2011FY2018
Net income
$3.2 billion
FY2011FY2018
Diluted EPS
$3.13
FY2011FY2018
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Revenue
21,493
19,974
18,313
+7.6%
Cost of revenue
4,682
4,448
4,160
+5.3%
Gross profit
16,812
15,526
14,152
+8.3%
Gross margin
78.2%
77.7%
77.3%
Research and development
5,051
5,096
5,040
-0.9%
Selling, general and administrative
5,975
5,982
5,842
-0.1%
Interest expense
242
225
185
+7.8%
Pre-tax income
3,680
2,305
3,276
+59.7%
Income tax
530
2,391
551
-77.9%
Effective tax rate
14.4%
103.7%
16.8%
Net income
3,232
-204
2,738
Net margin
15.0%
-1.0%
14.9%
Diluted EPS
$3.13
-$0.19
$2.58
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Operating cash flow
5,524
5,616
4,851
-1.6%
Capital expenditure
1,211
1,077
1,037
+12.4%
Free cash flow
4,314
4,539
3,814
-5.0%
Free cash flow margin
20.1%
22.7%
20.8%
Cash from investing
1,906
-3,784
-3,139
Cash from financing
-5,905
143
-560
Depreciation and amortisation
1,609
1,567
1,497
+2.7%
Share-based compensation
280
281
255
-0.6%
Buybacks
4,151
300
600
+1,284.5%
Dividends paid
2,312
2,192
2,158
+5.5%
Dividend per share
$2.33
$2.12
$2.05
+9.9%
Diluted shares, weighted
1,034m
1,052m
1,062m
-1.7%
Balance sheet
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Shareholders' equity
9,829
11,592
14,008
-15.2%
Non-controlling interest
1,080
75.7
72.8
+1,327.2%
Debt
10,299
13,647
10,305
-24.5%
Operating lease liabilities
0.0
n/a
n/a
Other liabilities
22,701
19,666
14,420
+15.4%
Total liabilities and equity
43,908
44,981
38,806
-2.4%
Fixed assets
7,996
7,885
8,253
+1.4%
Goodwill
1,367
1,378
3,973
-0.8%
Intangible assets
1,068
1,354
4,358
-21.1%
Investments
2,094
7,164
6,664
-70.8%
Cash and equivalents
7,321
6,212
4,582
+17.9%
Receivables
4,594
3,977
4,029
+15.5%
Inventory
3,098
3,396
3,562
-8.8%
Other assets
16,371
13,614
3,385
+20.3%
Total assets
43,908
44,981
38,806
-2.4%
10-K for the year ended 31 December 2018, filed 19 February 2019: the filing.